{"DataElement":{"publicId":"2007184","version":"3","preferredName":"Laboratory Procedure Creatinine Eligibility Determination ind-2","preferredDefinition":"the yes/no indicator whether a medical procedure was performed that involves testing a sample of blood for creatinine, the breakdown product of creatine, a constituent of muscle tissue, that is excreted by the kidney and whose serum level is used to evaluate kidney function, as a method of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.","longName":"LAB_CREAT_ELIG_IND","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2778339","version":"1","preferredName":"Laboratory Procedure Creatinine Eligibility Determination","preferredDefinition":"information related to the medical procedure that involves testing a sample of blood for creatinine, the breakdown product of creatine, a constituent of muscle tissue, that is excreted by the kidney and whose serum level is used to evaluate kidney function, as a method of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.","longName":"LAB_CREAT_ELIG","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2543047","version":"1","preferredName":"Test","preferredDefinition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","longName":"C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2262D258-9F2F-4D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-11-16","modifiedBy":"ONEDATA","dateModified":"2006-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2778334","version":"1","preferredName":"Creatinine Eligibility Determination","preferredDefinition":"The breakdown product of creatine, a constituent of muscle tissue, that is excreted by the kidney and whose serum level is used to evaluate kidney function.(NCI):Criteria to determine eligibility of patients for medical care programs and services.","longName":"C399:C25171","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Creatinine","conceptCode":"C399","definition":"The breakdown product of creatine, a constituent of muscle tissue, that is excreted by the kidney and whose serum level is used to evaluate kidney function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Eligibility Determination","conceptCode":"C25171","definition":"The act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"55729108-8A20-0F89-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-08-27","modifiedBy":"ONEDATA","dateModified":"2008-08-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"55729108-8A31-0F89-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-08-27","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811909","version":"1","longName":"Leukemia","context":"CTEP"},{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811954","version":"1","longName":"Eligibility Criteria","context":"CTEP"}]},{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104894","version":"1","longName":"GOG-0231D","context":"NRG"},{"publicId":"4104916","version":"1","longName":"GOG-0257","context":"NRG"},{"publicId":"10000500","version":"1","longName":"GOG-0257","context":"NRG"},{"publicId":"10000499","version":"1","longName":"GOG-0257","context":"NRG"}]},{"publicId":"4254096","version":"1","longName":"Protocol Phase","context":"PBTC","ClassificationSchemeItems":[{"publicId":"10000103","version":"1","longName":"Phase I","context":"PBTC"},{"publicId":"4254119","version":"1","longName":"PBTC-042","context":"PBTC"}]}],"AlternateNames":[{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"NRG","type":"USED_BY","context":"NRG"},{"name":"LAB_CREAT_ELIG_IND","type":"USED_BY","context":"NRG"},{"name":"Alliance","type":"USED_BY","context":"Alliance"}],"ReferenceDocuments":[{"name":"Serum creatinine less than 1.","type":"Preferred Question Text","description":"Serum creatinine less than 1.5 mg/dl or calculated creatinine clearance greater than or equal to 60 ml/min/1.73m^2 using Cockcroft-Gault equation","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Serum Creatinine <=1.5 x ULN","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Creatinine <= 1.5 mg/dL or a calculated creatinine clearance of >= 50 ml/min (24-hour urine collection)","url":null,"context":"CTEP"},{"name":"CRF Text2","type":"Alternate Question Text","description":"Creatinine <=1.5 x ULN","url":null,"context":"CTEP"},{"name":"CRF Text7","type":"Alternate Question Text","description":"Creatinine <=1.5 x ULN OR creatinine clearance >=60 mL/min/1.73 m2 for patients with creatinine levels >1.5 x ULN","url":null,"context":"CTEP"},{"name":"CRF Text5","type":"Alternate Question Text","description":"Serum creatinine <=1.5 x ULN; if >1.25 x ULN calculated creatinine clearance must be >=60 ml/min","url":null,"context":"CTEP"},{"name":"CRF Text6","type":"Alternate Question Text","description":"Serum creatinine less than or equal to Institutional ULN OR creatinine clearance greater than or equal to 60 mL/min/1.73 m2 (calculated or measured)","url":null,"context":"CTEP"},{"name":"CRF Text8","type":"Alternate Question Text","description":"Is the Serum creatinine less than or equal to 2.5 mg/dl?","url":null,"context":"CTEP"},{"name":"CRF Text3","type":"Alternate Question Text","description":"Serum creatinine <= 1.5 x upper limit of normal (ULN)","url":null,"context":"CTEP"},{"name":"CRF Text4","type":"Alternate Question Text","description":"Is this patient's creatinine >1.5 x institutional ULN and/or creatinine clearance <60 mL/min due to non-Hodgkin's lymphoma?","url":null,"context":"CTEP"},{"name":"CRF Text9","type":"Alternate Question Text","description":"Is pre-study creatinine <= 2.0 upper limit or normal OR creatinine clearance (est. DFT (Cockcroft-Gault)) >= 30 mL/min within 7 days prior to first dose of study drug?","url":null,"context":"CTEP"},{"name":"CRF Text 10","type":"Alternate Question Text","description":"Creatinine clearance >=60 mL/min/1.73 m2 for patients with creatinine levels above institutional normal","url":null,"context":"CTEP"},{"name":"CRF Text 11","type":"Alternate Question Text","description":"Serum creatinine level within normal institutional limits OR a creatinine clearance of at least 60 mL/min within 14 days prior to registration","url":null,"context":"NRG"},{"name":"PBTC_Text1","type":"Alternate Question Text","description":"Creatinine Clearance >=70 mL/min/1.73 m2 or Serum Creatinine level within normal limits based on age/gender","url":null,"context":"PBTC"},{"name":"PBTC_Text2","type":"Alternate Question Text","description":"Creatinine Clearance >=70 mL/min/1.73 m2 or Serum Creatinine level within normal limits based on age/gender, per protocol","url":null,"context":"PBTC"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Does patient have a serum creatinine >3.0 mg/dL?","url":null,"context":"CTEP"},{"name":"NRG CRF text1","type":"Alternate Question Text","description":"Estimated creatinine clearance greater than or equal to 50 ml/min/1.73m^2 using Cockcroft-Gault formula?","url":null,"context":"NRG"},{"name":"CRF Text12","type":"Alternate Question Text","description":"Serum creatinine <= 2.0 mg/dL","url":null,"context":"Alliance"},{"name":"NRG CRF_Text12","type":"Alternate Question Text","description":"Serum creatinine less than or equal to 1.5 x institutional upper limit normal (ULN) or measured or calculated creatinine clearance greater than or equal to 50 mL/min (for subjects with creatinine levels 1.5 x greater than institutional  ULN).","url":null,"context":"NRG"},{"name":"CRF Text20","type":"Alternate Question Text","description":"Creatinine clearance >50 mL/min estimated by Cockcroft-Gault formula?","url":null,"context":"NRG"},{"name":"CRF Text21","type":"Alternate Question Text","description":"Creatinine less than or equal to 1.5 Or Cal. Creatinine Clearance greater than or equal to 50","url":null,"context":"Alliance"},{"name":"CRF Text22","type":"Alternate Question Text","description":"Creatinine Met Criteria","url":null,"context":"Alliance"},{"name":"CRF Text13","type":"Alternate Question Text","description":"Is this patient's Creatinine greater than the age-gender-specific norms established per Protocol Section 3.2?","url":null,"context":"Alliance"},{"name":"CRF Text14","type":"Alternate Question Text","description":"Is this patient's Creatinine greater than 1.0 x institutional ULN?","url":null,"context":"Alliance"},{"name":"CRF Text23","type":"Alternate Question Text","description":"Calculated Creatinine Clearance greater than or equal to 30 mL/min by Cockcroft-Gault formula?","url":null,"context":"Alliance"},{"name":"NRG_eCRF_Text","type":"Alternate Question Text","description":"Is creatinine clearance (CrCL) or estimated Glomerular filtration rate (eGFR) greater than 50 mL/min estimated using either the Cockcroft-Gault equation, the Modification of Diet in Renal Disease Study, or as reported in the comprehensive metabolic panel/basic metabolic panel (eGFR)?","url":null,"context":"NRG"},{"name":"CRF Text24","type":"Alternate Question Text","description":"Is this patient's Creatinine > 1.5 x institutional ULN?","url":null,"context":"Alliance"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Does serum creatinine meet criteria outlined the protocol?","url":null,"context":"COG"}],"origin":"CALGB CRF:Cancer and Leukemia Group B Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE2DFA4C-C228-417E-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-05-21","endDate":null,"createdBy":"CVALMONT","dateCreated":"2003-05-21","modifiedBy":"KUMMEROA","dateModified":"2023-08-14","changeDescription":"Replaced VD Eligibility Ind-2 2018257v1 with VD ID#3506068 - Yes No Indicator - dbw","administrativeNotes":"2023.8.14 AQT added per ticket request CADSR0002739. ak 7/20/2022: fixed the box symbol in AQTs.wz","unresolvedIssues":null,"deletedIndicator":"No"}}